FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?
Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these fragments. A machine-learning system then analyzes the results for signals that could point to cancer.